Top Markets
#1 Islamic Coin Islamic Coin +151.50%
#2 DOVU DOVU +50.13%
#3 Black Phoenix Black Phoenix +35.32%
#4 Velvet Velvet +31.51%
#5 Palladium Network Palladium Network +20.62%
#6 Akedo Akedo +19.78%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.32%
#8 Fake World Assets Fake World Assets +17.01%
#9 DoubleZero DoubleZero +12.65%
#10 clBTC clBTC +11.86%
Coin of the day
Islamic Coin Islamic Coin
Ρυθμίσεις
Γλώσσα
Ελληνικά
Νόμισμα
USD
Θέμα
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
Κατάταξη σε μετοχές #39914
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
Τιμή μετοχής
$0.00366968
Τελευταίος συγχρονισμός: 2024-07-12
Κεφαλαιοποίηση
$299.46K
Αλλαγή (1 ημέρα)
-66.77%
Αλλαγή (1 έτος)
0.00%
Χώρα
CA
Εμπόριο Biocure Technology Inc. (CURE)

Κατηγορία

Healthcare
Ιστορικό τιμής μετοχής για την Biocure Technology Inc. (CURE)
Υψηλότερη τιμή κλεισίματος: $0.00 στις 2024-07-01

Χαμηλότερη τιμή κλεισίματος: $0.01 στις 2009-03-01
Ιστορικό τιμής μετοχής της Biocure Technology Inc. από 2009 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2024 -66.52%
2023 45.61%
2022 -93.00%
2021 -11.53%
2020 -23.85%
2019 -54.33%
2018 42.23%
2017 3,176.92%
2016 2.72%
2015 68.45%
2014 -68.19%
2013 -16.07%
2012 -65.37%
2011 376.76%
2010 -26.05%
2009 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 32.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 31.47%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 9.07%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.09%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 14.81%
BE